EUVIMEDEUVIMED entdecken
LeserbriefSystematische ÜbersichtMetaanalyse

Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sana Gupta iD, Jia Qi Adam Bai, Ilya Mukovozov

Dermatitis® · 15.07.2026

DOI: 10.1177/17103568261470925 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Dermatitis®, online erschienen am 15.07.2026. Verfasst von Sana Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Canada. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Medicine, University of Ottawa, Ottawa, Canada.
  • Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada.
  • Department of Medicine, Division of Dermatology, Women's College Hospital, Toronto, Canada.

ORCID-Profile: Sana Gupta

Zitieren

APA

Gupta, S., Bai, J. Q. A., & Mukovozov, I. (2026). Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dermatitis®. https://doi.org/10.1177/17103568261470925

Vancouver

Gupta S, Bai JQA, Mukovozov I. Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dermatitis®. 2026. doi:10.1177/17103568261470925

BibTeX
@article{Gupta2026,
  author = {Gupta, Sana and Bai, Jia Qi Adam and Mukovozov, Ilya},
  title = {Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Dermatitis®},
  year = {2026},
  doi = {10.1177/17103568261470925}
}
Kostenlos starten →